Gene Query: GMFG

Dataset Description Geneva Score
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 118.47
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 47.05
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 41.31
SRSF2 mutations impair hematopoiesis and alter exon recognition 39.57
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 35.58
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 34.61
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 31.48
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 30.92
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 27.76
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 23.11
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 22.92
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 22.71
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 22.53
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 22.22
RNA-seq data from human lymphoma cell lines 22.19
ChIP-seq and RNA-seq from human lymphoma cell lines 22.19
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 21.61
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 21.52
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 20.7
Transcriptome-wide identification of CELF2 functional targets in T cells 20.25
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 19.81
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 19.66
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 19.66
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 19.02
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 18.93
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 18.93
Seletive inhibition of CDK9 in DLBCL cell lines 18.57
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 18.15
Transcriptional changes in lymphoma cells induced by LSD1 depletion 18.15
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 18.09
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 17.93
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 17.91
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 17.26
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 17.26
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 16.94
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 16.56
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 16.41
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 16.19
Total RNA-seq in ALL-SIL upon JQ1 inhibition 15.42
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 15.19
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 15.19
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 14.66
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 14.33
Role of cervicovaginal microbiota in genital inflammation 14.09
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 14.04
Transcriptional profiling of microglia; current state of the art and future perspectives 13.81
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 13.71
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 13.66
CD86 regulates a pro-survival signal in myeloma cells 13.62
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 13.4
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 13.4
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 13.33
Impact of dieldrin on transcription in Jurkat T cells 13.14
Trans-differentiation of human adult peripheral blood T cells into neurons 13.06
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 12.99
RNA-seq analysis of AML cells in response to ASLAN003 12.48
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 12.33
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 12.14
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 11.88
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 11.88
Global gene expression profile of dasatinib-resistant RCH-ACV cells 11.84
Stem and effector CD8 T-cells from human cancers 11.75
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 11.63
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 11.54
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 11.54
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 11.51
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 11.46
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 11.44
CROP-Seq in Primary Human T Cells 11.38
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 11.37
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 11.36
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 11.31
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 11.24
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 10.84
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 10.84
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 10.74
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 10.61
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 10.52
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 10.51
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 10.4
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 10.32
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 10.32
Characterization of human ILC2 subsets 10.27
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 10.23
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 9.94
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 9.94
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 9.93
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 9.93
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 9.92
BCL11B 9.89
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 9.88
Transcriptomic analysis of LSD1 9.86
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 9.84
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 9.8
Human neutrophil genome during PMA- and E. coli encounter-induced activation 9.8
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 9.71
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 9.66
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 9.66
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 9.64
Gene expression changes associated with resistance to tagraxofusp (SL-401) 9.47
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 9.45
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 9.28
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 9.27
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 9.2
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 9.17
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 9.17
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 9.06
mRNA expression profile of Lymphocytes 8.95
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 8.88
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 8.88
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 8.88
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 8.79
Non-coding regions are the main source of tumor-specific antigens 8.67
Non-coding regions are the main source of tumor-specific antigens [human] 8.67
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 8.67
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 8.64
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 8.61
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 8.41
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 8.26
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.18
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 8.17
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 8.13
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 8.06
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.0
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 7.99
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 7.97
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 7.97
Global analysis of enhancer targets: Mosaic-seq 7.94
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 7.88
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 7.87
JAK dependent survival of ALK- ALCL 7.85
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 7.85
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 7.69
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 7.69
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 7.67
Identification of renal resident macrophages across species 7.62
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 7.62
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 7.57
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 7.53
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 7.53
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 7.35
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 7.33
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 7.32
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 7.26
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 7.24
Landscape and variation of RNA secondary structure across the human transcriptome 7.08
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 7.0
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 6.89
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 6.82
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 6.81
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 6.75
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 6.75
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.67
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 6.66
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 6.66
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 6.63
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 6.63
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 6.63
MEIS1 regulates hematopoiesis in hPSCs 6.61
Short and Long RNA sequencing of human mature erythrocytes 6.59
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 6.51
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 6.51
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 6.36
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 6.34
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 6.32
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 6.28
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 6.26
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 6.23
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 6.23
The evolution of N6-methyladenosine in primates 6.22
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 6.22
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 6.2
Transcriptomes of human monocytes after ex vivo exposure to uric acid 6.15
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.12
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 6.04
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 6.02
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.0
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.0
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 6.0
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 5.97
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.95
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 5.93
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 5.85
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 5.83
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.83
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 5.82
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.8
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 5.79
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 5.78
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 5.77
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 5.72
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 5.62
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 5.62
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 5.52
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 5.48
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 5.44
miRNAs affected by antagomiR-17 treatment 5.42
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 5.39
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 5.35
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 5.35
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 5.32
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 5.3
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 5.3
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 5.27
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 5.26
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 5.25
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 5.22
The comparison of high-throughput single-cell RNA-seq methods 5.16
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 5.14
A novel target of EZH1/2 for treatment of mantle cell lymphoma 5.12
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 5.08
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 5.05
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 5.05
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 5.04
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 5.01
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 5.0
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 4.98
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 4.98
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 4.92
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 4.87
RNA-seq of stable and unstable section of human atherosclerotic plaques 4.82
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 4.78
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 4.77
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 4.76
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 4.74
The human blood-nerve barrier transcriptome 4.74
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 4.6
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 4.59
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 4.59
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 4.5
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 4.47
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 4.47
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 4.44
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 4.44
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 4.44
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 4.43
A Unique Epigenomic Landscape Defines Human Erythropoiesis 4.43
A map of gene expression in neutrophil-like cell lines 4.4
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 4.32
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 4.31
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.31
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.31
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 4.31
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 4.31
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 4.3
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 4.3
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 4.28
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.25
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 4.24
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 4.21
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.2
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 4.19
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 4.18
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 4.13
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 4.13
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 4.07
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 4.06
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 4.03
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 4.01
Transcriptomic analysis of human tonsillar TFH subsets 3.98
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 3.98
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 3.98
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.93
Gene expression profile of multiple myeloma cell lines treated with CB-5083 3.92
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 3.88
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 3.85
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 3.84
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 3.84
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 3.8
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 3.8
An optimization system for isolating and sequencing of single human colon cancer cells 3.79
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 3.77
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.76
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 3.74
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 3.73
Primary Human B-cell Temporal Response to CD40L Stimulation 3.73
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.72
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 3.69
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.68
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 3.68
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.65
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.61
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 3.6
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 3.59
Gene expression profiling of leukemia cells following asparagine depletion 3.59
Transcriptome analysis of peripheral blood monocytes 3.55
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.54
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 3.54
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 3.54
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.51
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 3.5
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 3.5
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 3.49
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 3.41
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 3.34
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 3.34
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 3.31
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 3.29
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 3.28
RNA Seq of HMVEC under hypoxia 3.28
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.28
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 3.27
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 3.25
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.23
Loss of CREBBP results in gene expression repression in lymphoma cells 3.23
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 3.23
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 3.22
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.19
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 3.18
Widespread intronic polyadenylation diversifies immune cell transcriptomes 3.18
Total RNA-Seq data from leukemic patients with complex structural variants 3.18
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.17
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 3.15
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 3.12
Generation and functional characterization of MDSC-like cells 3.12
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 3.11
Irf9 function in immunity in mouse 3.06
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 3.06
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 3.01
TT-Seq captures the human transient transcriptome 2.98
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.95
Functional significance of the HIV-1 Tat signature amino acid residues 2.95
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.93
Transcriptome analysis of CNS leukemia 2.93
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 2.92
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 2.86
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 2.86
Transcriptome analysis of SKI knock-out in HL60 cells 2.85
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.85
Human Treg IFNg/IL-10 subpopulations 2.84
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.82
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.82
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.82
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 2.78
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 2.77
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.75
Morphological and molecular characterization of human dermal lymphatic collectors 2.74
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 2.73
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 2.73
Comprehensive comparative analysis of 5’ end RNA sequencing methods 2.7
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 2.69
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 2.67
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 2.67
RNA sequencing of primary human platelets and in vitro cell lines 2.65
Peptidomimetic blockade of MYB in acute myeloid leukemia 2.64
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 2.64
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 2.52
Transcriptome of activated human and mouse MAIT cells 2.5
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 2.47
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 2.43
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 2.43
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.38
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 2.33
Impact on erythroid progenitor type on erythroid differntiation 2.32
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 2.31
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 2.29
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.27
RNA-Seq and expression data from human adipose tissue 2.27
Reprogrammed myeloid cell transcriptomes in NSCLC 2.26
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 2.26
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 2.25
Transcriptomes in healthy and CHB fetal hearts 2.24
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 2.22
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 2.21
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 2.19
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 2.15
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.14
Hepatosplenic T cell lymphoma 2.14
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 2.14
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.09
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.07
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 2.05
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.05
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.05
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.04
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.04
RNA sequencing of T-ALL (COG study) 2.03
Analyses of T-ALL (COG study) 2.03
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 2.03
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.99
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 1.97
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.91
Total RNA-seq in ALL-SIL upon TLX1 knockdown 1.86
Single-cell analysis of adult human ovary using 10X genomics 1.82
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.8
MARCKS and lnc-MARCKS act as inflammation regulators 1.77
Gene expression activation in CLL mediated by MSCs contact 1.77
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.75
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.72
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.67
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 1.66
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.62
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.58
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.58
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 1.57
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 1.57
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 1.57
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 1.55
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 1.55
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.54
NAPRT activation of macrophages 1.52
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 1.49
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.49
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.47
LncRNA expression profiling of ischemic stroke patients 1.45
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.43
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.43
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 1.43
Dermal endothelial cells of type 2 diabetic patients 1.4
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 1.4
Macrophage Ad5f35 PhenoMap 1.35
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.34
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 1.29
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.29
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.29
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.27
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.25
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 1.24
In situ CAPTURE of chromatin interactions by biotinylated dCas9 1.24
U2AF1 mutations alter splice site recognition in hematological malignancies 1.21
MHC Transcriptomic landscape at haplotype-specific resolution 1.2
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.2
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.17
Efficient derivation of microglia-like cells from human pluripotent stem cells 1.11
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 1.07
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 1.06
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.06
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 1.06
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 1.05
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 1.03
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 1.02
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 1.01
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.99
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 0.99
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 0.99
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.96
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.96
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 0.93
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 0.92
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.88
Gene expression profile of CRC-derived HILEC 0.88
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.86
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.84
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 0.8
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 0.8
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 0.79
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.79
Aging-associated patterns in the expression of human endogenous retroviruses 0.77
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.77
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.77
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.76
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.73
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.73
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.72
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.65
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.62
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.61
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.6
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.59
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.57
naive T cell heterogeneity after neonatal thymectomy 0.55
Intrahepatic MAIT cell gene expression revealed by RNA-seq 0.55
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.54
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.53
Human Tfh cell RNA bulk sequencing 0.52
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.51
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.51
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.49
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.49
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.48
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.46
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.44
RNA-seq of primary patient AML samples 0.44
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.4
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.4
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 0.35
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.34
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.34
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.34
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.32
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.32
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.28
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.28
RNA-seq data 0.27
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.25
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.25
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 0.15
TAF1 is critical for AE driven leukemogenesis 0.15
Oncogenic roles of ARID5B in T-ALL 0.14
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.14
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.13
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 0.12
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 0.12
The Genetic Landscape of Diamond-Blackfan Anemia 0.11
The cytokine environment influence on human skin-derived T cells 0.08
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.03
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.03
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.03
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.01
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation